Why the study?
Does growth hormone replacement provide benefits and is it safe in adults with growth hormone deficiency?
Does growth hormone replacement provide benefits and is it safe in adults with growth hormone deficiency?
Growth hormone replacement in GH-deficient adults provides lifelong benefits without increasing the risk of malignancy.
Supports lifelong GH replacement in GH-deficient adults; reinforces consensus on benefits and malignancy safety.
BACKGROUND: The Growth Hormone Research Society held a Consensus Workshop in Sydney, Australia, in March 2007 to review advances in the management of growth hormone (GH) deficiency in adults and to update consensus recommendations. OBJECTIVE: This short review summarizes key background information presented at the workshop and the consensus recommendations that followed. CONCLUSIONS: The benefits of GH replacement in GH-deficient adults are evident throughout life. Clinical response to treatment should be assessed by monitoring biochemistry values, body composition and quality of life. There is no evidence that GH replacement increases the risk of tumour recurrence or de novo malignancy.
No takes yet. Share an insight, caveat, or question.
Gudmundur Johannsson (2009) conducted a review in Growth hormone deficiency in adults. Growth hormone replacement was evaluated. Growth hormone replacement in GH-deficient adults provides lifelong benefits and does not increase the risk of tumor recurrence or de novo malignancy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: